Target intelligence / Profile preview

Small EDRK-rich factor 2 pseudogene (SERF2 pseudogene)

Target
SERF2 pseudogene
Molecular classification
Pseudogene, Other (non-coding DNA)
01

Overview

The small EDRK-rich factor 2 pseudogene (ENSG00000270257) shares sequence homology with the functional *SERF2* gene, which encodes a small protein with high content of the amino acids glutamic acid (E), aspartic acid (D), arginine (R), and lysine (K)[5]. Pseudogenes are nonfunctional DNA segments that resemble known genes, but lack the ability to produce functional protein products due to disabling mutations such as frameshifts, premature stop codons, or loss of regulatory elements[2][4][6]. While some pseudogenes have been implicated in subtle regulatory roles within cells, notably by acting as microRNA decoys, there is no established evidence supporting such a biological function for ENSG00000270257[6]. Consequently, it is not recognized as a therapeutic target, receptor, enzyme, transporter, or biomarker in clinical practice or drug development. If you need information about the functional version of this gene, refer to “Small EDRK-rich factor 2” (*SERF2*), not the pseudogene version[5].

Other names
small EDRK-rich factor 2 pseudogeneSERF2 pseudogeneSmall EDRK-rich factor 2 (SERF2) Pseudogene
02

Mechanism of action

null

03

Biological functions

Other (no direct protein-coding function; occasionally, pseudogenes may participate in gene regulation through RNA transcripts, but this is not established for this specific locus)
04

Disease associations

Other (no direct evidence linking this pseudogene to specific disease phenotypes; some pseudogenes have regulatory effects, but this is not established here)

Beyond the preview

Go deeper on Small EDRK-rich factor 2 pseudogene (SERF2 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small EDRK-rich factor 2 pseudogene (SERF2 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call